Growth & profitability
- Revenue has grown 120.2% per year over the past 3 years.
- Operating margin has expanded, at 20.3% in the latest year.
ALAB Financials Astera Labs
4 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
ROEROA
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $853M | $219M | 75.7% | 20.3% | 16.1% | 14.3% | $282M | — | $168M |
| 2024 | $396M | -$83M | 76.4% | -29.3% | -8.6% | -7.9% | $102M | — | $80M |
| 2023 | $116M | -$26M | 68.9% | -25.5% | 26.9% | -13.4% | -$15M | — | $45M |
| 2022 | $80M | -$58M | 73.5% | -75.4% | 68.4% | — | -$40M | — | — |
RevenueNet income
GrossOperatingNet
ROEROA
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Mar '26 | $308M | $80M | 76.3% | 20.1% | 5.4% | 4.8% | $67M | — | $148M |
| Dec '25 | $271M | $45M | 75.6% | 24.7% | 3.3% | 2.9% | $77M | — | $168M |
| Sep '25 | $231M | $91M | 76.2% | 24.0% | 7.2% | 6.5% | $66M | — | $140M |
| Jun '25 | $192M | $51M | 75.8% | 20.7% | 4.5% | 4.0% | $133M | — | $162M |
| Mar '25 | $159M | $32M | 74.9% | 7.1% | 3.1% | 2.8% | $6M | — | $86M |
| Dec '24 | $141M | $25M | 74.0% | 0.1% | 2.6% | 2.3% | $24M | — | $80M |
| Sep '24 | $113M | -$8M | 77.7% | -7.9% | -0.9% | -0.8% | $47M | — | $126M |
| Jun '24 | $77M | -$8M | 77.9% | -31.7% | -0.9% | -0.8% | $31M | — | $421M |
| Mar '24 | $65M | -$93M | 77.4% | -127.1% | -11.5% | -10.8% | $228000 | — | $696M |
| Dec '23 | $51M | $14M | 77.3% | 17.9% | -14.7% | 7.3% | $13M | — | $45M |
| Sep '23 | $37M | -$3M | 76.1% | -5.4% | 2.7% | — | -$1M | — | — |
| Jun '23 | $11M | -$20M | 79.0% | -164.8% | 17.1% | — | -$24M | — | — |
| Mar '23 | $18M | -$17M | 24.1% | -107.2% | 17.5% | — | -$4M | — | — |
Valuation over time
How the market has priced ALAB against its own fundamentals since 2024-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-earnings ratio has risen from 131.7× (Dec '25) to 223.7× (Sep '26).
- The price-to-sales ratio has fallen from 109.9× (Mar '24) to 57.5× (Sep '26).
P/E
P/S
Frequently asked questions
Is ALAB growing its revenue and profit?
Over the past 3 years, Astera Labs's revenue has grown 120.2% per year. These are computed facts, not advice.
How much debt does ALAB have?
As of FY2025, Astera Labs reported — of total debt against $168M of cash.
What is ALAB's profit margin?
In FY2025, gross margin was 75.7%, operating margin 20.3%, and net margin 25.7%.
What is ALAB's P/E ratio?
As of Sep '26, Astera Labs traded at a price-to-earnings ratio of about 223.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.